FDA Inspection
The Ritedose CorporationThe Ritedose Corporation – FDA Inspection, Feb 28, 2025
Record Details
This FDA Inspection record concerns The Ritedose Corporation, with an inspection on February 28, 2025, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · a638648e-fc4d-4d6f-a757-610ee0f71120
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1250871
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.42(c)Defined areas of adequate size for operations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Ritedose Corporation
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 18, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 16, 2018 | Not classified | Atlanta District Office | |
| March 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 31, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Ritedose Corporation
- FDA Inspection 1165123 - 2022-03-22
- FDA Inspection 1089541 - 2019-04-18
- FDA Inspection 1045279 - 2018-02-16
- FDA Inspection 1015894 - 2017-03-03
- FDA Inspection 940802 - 2015-07-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.